June 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountimfinzi.com
Global Rank
#704,713
35,003Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
83.21%
Pages per Visit
1.23
Avg Visit Duration
00:00:12
- Company
- - -
- Industry
- - -
Top 10 imfinzi.com Competitors
The Top 10 Sites Like imfinzi.com in June 2026 are ranked by their affinity to imfinzi.com in terms of keyword traffic, audience targeting, and market overlap
Learn about TAGRISSO® (osimertinib) for the treatment of metastatic and resectable EGFRm NSCLC by contacting a representative.
- Company
- - -
- Industry
- - -
Global Rank
#1,281,825
32,143Bounce Rate
60.41%
Pages per Visit
1.68
Avg Visit Duration
00:00:47
Similarity Score
100%The official healthcare provider website for RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) and RYBREVANT® (amivantamab-vmjw), treatments for EGFR+ mNSCLC. See full Prescribing & Safety Information.
- Industry
- N/A
Bounce Rate
36.69%
Pages per Visit
3.27
Avg Visit Duration
00:03:14
Similarity Score
97%View helpful FAQs and term definitions about RYBREVANT FASPRO™ and RYBREVANT®, treatment, and support programs. See full Prescribing & Safety Information.
- Company
- - -
- Industry
- - -
Global Rank
#2,501,919
170,639Bounce Rate
53.17%
Pages per Visit
1.31
Avg Visit Duration
00:00:04
Similarity Score
96%learn about tagrisso® (osimertinib), a targeted treatment option for people with certain types of egfr+ non-small cell lung cancer (nsclc). talk to your doctor to see if tagrisso is right for you.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
74.06%
Pages per Visit
1.62
Avg Visit Duration
00:01:23
Similarity Score
93%health care professionals may find information about fda-approved indications for keytruda® (pembrolizumab) along with keynote clinical trials and treatment guidelines.
- Company
- - -
- Industry
- - -
Global Rank
#785,350
91,208Bounce Rate
57.98%
Pages per Visit
1.40
Avg Visit Duration
00:00:29
Similarity Score
91%Learn about BRAFTOVI® (encorafenib) an Rx combination treatment for certain BRAF positive (BRAF+) cancer types and see risks & benefits.
- Company
- - -
- Industry
- - -
Bounce Rate
58.34%
Pages per Visit
1.53
Avg Visit Duration
00:00:16
Similarity Score
89%CABOMETYX® (cabozantinib) is a multi-indication cancer treatment FDA-approved for 1L & 2L aRCC, 2L HCC and 2L DTC. See Important Safety Information.
- Company
- - -
- Industry
- - -
Bounce Rate
76.81%
Pages per Visit
1.32
Avg Visit Duration
00:02:13
Similarity Score
88%Find answers to frequently asked questions about VYLOY® and advanced stomach cancer. Please see full Prescribing Information.
- Company
- - -
- Industry
- - -
Bounce Rate
82.87%
Pages per Visit
1.18
Avg Visit Duration
00:00:15
Similarity Score
87%Learn more about PADCEV®. Find information on efficacy, dosing, resources, and more. Please see full Patient Information, including Serious Side Effects.
- Company
- - -
- Industry
- - -
Global Rank
#816,601
213,770Bounce Rate
80.72%
Pages per Visit
1.36
Avg Visit Duration
00:00:34
Similarity Score
86%Evaluate ORSERDU®, a treatment option for ESR1-mutated, ER+/HER2- advanced or metastatic breast cancer following disease progression on endocrine therapy.
- Company
- - -
- Industry
- - -
Bounce Rate
85.6%
Pages per Visit
1.16
Avg Visit Duration
00:00:10
Similarity Score
84%imfinzi.com's top 5 competitors in June 2026 are: tagrissohcp.com, rybrevanthcp.com, rybrevant.com, tagrisso.com, and more.
According to Similarweb data of monthly visits, imfinzi.com’s top competitor in June 2026 is tagrissohcp.com. imfinzi.com 2nd most similar site is rybrevanthcp.com, and closing off the top 3 is rybrevant.com.
tagrisso.com ranks as the 4th most similar website to imfinzi.com and keytrudahcp.com ranks fifth in June 2026.
The other five competitors in the top 10 list are braftovi.com, cabometyxhcp.com, vyloy.com, padcev.com, and orserdu.com.